Blood Screening Market Size & Share, by Technology (Nucleic Acid Testing, Rapid Tests, Western Blot Assay, ELISA, Next-Generation Sequencing); Product Type (Reagents & Kits, Instruments); End-user (Hospitals, Clinical Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4480
  • Published Date: Aug 02, 2023
  • Report Format: PDF, PPT

Companies Dominating the Blood Screening Landscape

top-features-companies
    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Grifols, S.A.
    • Quotient Limited
    • Thermo Fisher Scientific Inc.
    • BD
    • Ortho Clinical Diagnostics
    • DiaSorin S.p.A.
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Beckman Coulter, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Grifols, S.S. announced an agreement with Canadian Blood Services to boost the country’s independence in immunoglobulins medicines and plasma-protein therapies for Canada.
  • Quotient Limited announced the partnership with Theradiag for the development of autoimmune disease diagnostics by integrating it with automatic multiplexed solutions.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4480
  • Published Date: Aug 02, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising number of people suffering with chronic diseases, higher blood transfusions and increased cases of infectious diseases are the major factors driving the market growth.

The market size of blood screening is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho Clinical Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc., and Abbott Laboratories

The ELISA segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying